ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,843 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryHägendorfMedvisis Switzerland AG
Medvisis Switzerland AG Logo
Verified· 2 sources

Medvisis Switzerland AG

Summary

About the company

Medvisis Switzerland AG is a healthcare company that registers and commercializes pharmaceutical products from international pharmaceutical and biotech firms. It focuses on specialty, rare-disease and hospital products and provides in-licensing or commercialization agreements, product registration with Swissmedic, reimbursement and market-access support, and commercialization supported by a network of key opinion leaders.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered8
Pharmaceutical commercialisation and market access
Product registration with Swissmedic, product reimbursement and market access, as well as rapid launch and commercialisation of medicines in Switzerland.
In-licensing of medicines
In-licensing of innovative assets with unmet medical need from companies without a Swiss subsidiary; focus on unmet medical need and commercialisation in Switzerland.
Exclusive marketing and distribution rights for licensed products
Exclusive marketing rights in Switzerland and Liechtenstein for selected products, including ophthalmic, gastroenterology and other pharmaceutical preparations.
Therapy for Primary Mitochondrial Diseases
Commercialisation of a Phase-3 tested product for primary mitochondrial diseases in Switzerland and Liechtenstein.
Treatment for wet age-related macular degeneration
Biosimilar-based treatment for wet AMD, focusing on anti-VEGF therapies and evidence-based care for Swiss physicians and patients.

Knowledge

No knowledge articles yet

Once Medvisis Switzerland AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Medvisis Switzerland AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Medvisis Switzerland AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Medvisis Switzerland AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Gässli 18
4614 Hägendorf

At a glance

Legal form
Corporation
UID
CHE-432.342.754
Founded
2024 · 2 years
Last commercial register change
November 19, 2024
Employees
1 to 10

Similar companies

CA
Centranova AG
Härkingen
PA
PROREGIA AG
Kestenholz
QB
QUADIRA BIOSCIENCES AG
Solothurn
AB
abc biopply ag
Solothurn